Clinical trial
Precision Medicine in Anesthesia: Genetic Component in Opioid-induced Respiratory Depression
NCT03441282 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Precision Medicine in Anesthesia: Genetic Component in Opioid-induced Respiratory Depression
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 30, 2018
- Completion date
- May 21, 2025
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory depression